Impact of new diagnostic pathway for gestational diabetes in time of COVID-19.

IF 0.8 Q4 OBSTETRICS & GYNECOLOGY

Obstetric Medicine Pub Date : 2023-06-01 DOI:10.1177/1753495X221094899

Betrice Walker, Jenna Edey, Leanne Hall, Kathleen Braniff, Clare Heal

{"title":"Impact of new diagnostic pathway for gestational diabetes in time of COVID-19.","authors":"Betrice Walker, Jenna Edey, Leanne Hall, Kathleen Braniff, Clare Heal","doi":"10.1177/1753495X221094899","DOIUrl":null,"url":null,"abstract":"Background: In April 2020, the diagnostic criteria for gestational diabetes mellitus (GDM) changed in Queensland, with the goal of reducing exposure of pregnant women to COVID-19.Methods: A retrospective clinical audit was conducted at a regional hospital to compare the incidence of GDM, and specific maternal and neonatal outcomes four months before and after the change in guidelines was implemented.Results: Less than 50% of diagnostic tests were performed according to new guidelines. There was a non-significant increase in the incidence of GDM (13.3% to 15.3%), and pharmacological treatments. Instrumental deliveries (p = 0.01) and shoulder dystocia (p = 0.04) increased following the change in guidelines. There were no differences in the incidence of elective and emergency caesarean delivery, macrosomia and fetal weight. Maternal pre-pregnancy body mass index (BMI) was higher in the COVID-19 GDM cohort (p = 0.02).Conclusions: Despite the change in guidelines, there was a non-significant increase in the incidence of diagnosis of gestational diabetes.","PeriodicalId":51717,"journal":{"name":"Obstetric Medicine","volume":"16 2","pages":"104-108"},"PeriodicalIF":0.8000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021731/pdf/10.1177_1753495X221094899.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetric Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1753495X221094899","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 1

Abstract

Background: In April 2020, the diagnostic criteria for gestational diabetes mellitus (GDM) changed in Queensland, with the goal of reducing exposure of pregnant women to COVID-19.

Methods: A retrospective clinical audit was conducted at a regional hospital to compare the incidence of GDM, and specific maternal and neonatal outcomes four months before and after the change in guidelines was implemented.

Results: Less than 50% of diagnostic tests were performed according to new guidelines. There was a non-significant increase in the incidence of GDM (13.3% to 15.3%), and pharmacological treatments. Instrumental deliveries (p = 0.01) and shoulder dystocia (p = 0.04) increased following the change in guidelines. There were no differences in the incidence of elective and emergency caesarean delivery, macrosomia and fetal weight. Maternal pre-pregnancy body mass index (BMI) was higher in the COVID-19 GDM cohort (p = 0.02).

Conclusions: Despite the change in guidelines, there was a non-significant increase in the incidence of diagnosis of gestational diabetes.

查看原文本刊更多论文

新诊断途径对妊娠期糖尿病的影响

背景:2020年4月，昆士兰州改变了妊娠期糖尿病(GDM)的诊断标准，目的是减少孕妇对COVID-19的暴露。方法:在一家地区医院进行回顾性临床审计，比较GDM的发病率，以及实施指南变更前后四个月的具体孕产妇和新生儿结局。结果:不到50%的诊断试验是按照新的指南进行的。GDM的发生率(13.3%至15.3%)和药物治疗均无显著增加。器械分娩(p = 0.01)和肩难产(p = 0.04)随着指南的改变而增加。择期和急诊剖宫产的发生率、巨大儿和胎儿体重均无差异。产妇孕前体重指数(BMI)在COVID-19 GDM队列中较高(p = 0.02)。结论:尽管指南发生了变化，但妊娠期糖尿病的诊断率并没有显著增加。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Obstetric Medicine OBSTETRICS & GYNECOLOGY-

CiteScore

1.90

自引率

0.00%

发文量